Histoplasmosis is an infection that occurs from breathing spores of a fungus called Histoplasma capsulatum. Histoplasmosis is a fungal infection that occurs throughout the world. Histoplasma fungus grows as a mold in the soil. The soil that contains the droppings of bat or birds usually contains large amount of this fungus. The people with weakened immune system are usually more prone and increases the risk of being affected or reactivated with histoplasmosis. Usually people very young, old people and people affected with cancer, AIDS or organ transplant have severe symptoms. The people with chronic lung disease such as bronchiectasis or emphysema have high risk of severe pain. The common symptoms of histoplasmosis is fever, chills, cough, chest pain, red skin bumps, mouth sores etc. In some patients suffering from histoplasmosis may spread throughout the body and cause irritation and swelling in response to infection.
Certain symptoms also includes chest pain from swelling in lining of heart, neck stiffness etc. The disease is usually diagnosed with biopsy of lungs, skin, liver or bone marrow. Certain blood and urine test also help in detection histoplasmosis proteins or antibodies of the fungus in body. In some cases doctors also perform Chest CT scan, Chest X-ray, Bronchoscopy etc.
In 2017, the global Histoplasmosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global Histoplasmosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Histoplasmosis Treatment development in United States, Europe and China.
The key players covered in this study
Bristol Myers Squibb
Sigma tau pharmaceuticals Inc.
Three rivers pharmaceuticals
Astellas pharma US Inc.
Abbott laboratories
Abraxis pharmaceutical products
Teva parenteral medicines Inc.
X gen pharmaceuticals Inc.
Market segment by Type, the product can be split into
Amphotericin B
Itraconazole
Ketoconazole
Other
Market segment by Application, split into
Hospitals Pharmacies
Private clinics
Drug stores and retail pharmacy
E-commerce
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Histoplasmosis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Histoplasmosis Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Histoplasmosis Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Histoplasmosis Treatment Market Size Growth Rate by Type (2013-2025)
1.4.2 Amphotericin B
1.4.3 Itraconazole
1.4.4 Ketoconazole
1.4.5 Other
1.5 Market by Application
1.5.1 Global Histoplasmosis Treatment Market Share by Application (2013-2025)
1.5.2 Hospitals Pharmacies
1.5.3 Private clinics
1.5.4 Drug stores and retail pharmacy
1.5.5 E-commerce
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Histoplasmosis Treatment Market Size
2.2 Histoplasmosis Treatment Growth Trends by Regions
2.2.1 Histoplasmosis Treatment Market Size by Regions (2013-2025)
2.2.2 Histoplasmosis Treatment Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Histoplasmosis Treatment Market Size by Manufacturers
3.1.1 Global Histoplasmosis Treatment Revenue by Manufacturers (2013-2018)
3.1.2 Global Histoplasmosis Treatment Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Histoplasmosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Histoplasmosis Treatment Key Players Head office and Area Served
3.3 Key Players Histoplasmosis Treatment Product/Solution/Service
3.4 Date of Enter into Histoplasmosis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Histoplasmosis Treatment Market Size by Type (2013-2018)
4.2 Global Histoplasmosis Treatment Market Size by Application (2013-2018)
5 United States
5.1 United States Histoplasmosis Treatment Market Size (2013-2018)
5.2 Histoplasmosis Treatment Key Players in United States
5.3 United States Histoplasmosis Treatment Market Size by Type
5.4 United States Histoplasmosis Treatment Market Size by Application
6 Europe
6.1 Europe Histoplasmosis Treatment Market Size (2013-2018)
6.2 Histoplasmosis Treatment Key Players in Europe
6.3 Europe Histoplasmosis Treatment Market Size by Type
6.4 Europe Histoplasmosis Treatment Market Size by Application
7 China
7.1 China Histoplasmosis Treatment Market Size (2013-2018)
7.2 Histoplasmosis Treatment Key Players in China
7.3 China Histoplasmosis Treatment Market Size by Type
7.4 China Histoplasmosis Treatment Market Size by Application
8 Japan
8.1 Japan Histoplasmosis Treatment Market Size (2013-2018)
8.2 Histoplasmosis Treatment Key Players in Japan
8.3 Japan Histoplasmosis Treatment Market Size by Type
8.4 Japan Histoplasmosis Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Histoplasmosis Treatment Market Size (2013-2018)
9.2 Histoplasmosis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Histoplasmosis Treatment Market Size by Type
9.4 Southeast Asia Histoplasmosis Treatment Market Size by Application
10 India
10.1 India Histoplasmosis Treatment Market Size (2013-2018)
10.2 Histoplasmosis Treatment Key Players in India
10.3 India Histoplasmosis Treatment Market Size by Type
10.4 India Histoplasmosis Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Histoplasmosis Treatment Market Size (2013-2018)
11.2 Histoplasmosis Treatment Key Players in Central & South America
11.3 Central & South America Histoplasmosis Treatment Market Size by Type
11.4 Central & South America Histoplasmosis Treatment Market Size by Application
12 International Players Profiles
12.1 Bristol Myers Squibb
12.1.1 Bristol Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Histoplasmosis Treatment Introduction
12.1.4 Bristol Myers Squibb Revenue in Histoplasmosis Treatment Business (2013-2018)
12.1.5 Bristol Myers Squibb Recent Development
12.2 Sigma tau pharmaceuticals Inc.
12.2.1 Sigma tau pharmaceuticals Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Histoplasmosis Treatment Introduction
12.2.4 Sigma tau pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2013-2018)
12.2.5 Sigma tau pharmaceuticals Inc. Recent Development
12.3 Three rivers pharmaceuticals
12.3.1 Three rivers pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Histoplasmosis Treatment Introduction
12.3.4 Three rivers pharmaceuticals Revenue in Histoplasmosis Treatment Business (2013-2018)
12.3.5 Three rivers pharmaceuticals Recent Development
12.4 Astellas pharma US Inc.
12.4.1 Astellas pharma US Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Histoplasmosis Treatment Introduction
12.4.4 Astellas pharma US Inc. Revenue in Histoplasmosis Treatment Business (2013-2018)
12.4.5 Astellas pharma US Inc. Recent Development
12.5 Abbott laboratories
12.5.1 Abbott laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 Histoplasmosis Treatment Introduction
12.5.4 Abbott laboratories Revenue in Histoplasmosis Treatment Business (2013-2018)
12.5.5 Abbott laboratories Recent Development
12.6 Abraxis pharmaceutical products
12.6.1 Abraxis pharmaceutical products Company Details
12.6.2 Company Description and Business Overview
12.6.3 Histoplasmosis Treatment Introduction
12.6.4 Abraxis pharmaceutical products Revenue in Histoplasmosis Treatment Business (2013-2018)
12.6.5 Abraxis pharmaceutical products Recent Development
12.7 Teva parenteral medicines Inc.
12.7.1 Teva parenteral medicines Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Histoplasmosis Treatment Introduction
12.7.4 Teva parenteral medicines Inc. Revenue in Histoplasmosis Treatment Business (2013-2018)
12.7.5 Teva parenteral medicines Inc. Recent Development
12.8 X gen pharmaceuticals Inc.
12.8.1 X gen pharmaceuticals Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Histoplasmosis Treatment Introduction
12.8.4 X gen pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2013-2018)
12.8.5 X gen pharmaceuticals Inc. Recent Development
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Histoplasmosis Treatment Key Market Segments
Table Key Players Histoplasmosis Treatment Covered
Table Global Histoplasmosis Treatment Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Histoplasmosis Treatment Market Size Market Share by Type 2013-2025
Figure Amphotericin B Figures
Table Key Players of Amphotericin B
Figure Itraconazole Figures
Table Key Players of Itraconazole
Figure Ketoconazole Figures
Table Key Players of Ketoconazole
Figure Other Figures
Table Key Players of Other
Table Global Histoplasmosis Treatment Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals Pharmacies Case Studies
Figure Private clinics Case Studies
Figure Drug stores and retail pharmacy Case Studies
Figure E-commerce Case Studies
Figure Histoplasmosis Treatment Report Years Considered
Table Global Histoplasmosis Treatment Market Size 2013-2025 (Million US$)
Figure Global Histoplasmosis Treatment Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Histoplasmosis Treatment Market Size by Regions 2013-2025 (Million US$)
Table Global Histoplasmosis Treatment Market Size by Regions 2013-2018 (Million US$)
Table Global Histoplasmosis Treatment Market Share by Regions 2013-2018
Figure Global Histoplasmosis Treatment Market Share by Regions 2013-2018
Figure Global Histoplasmosis Treatment Market Share by Regions 2018
Table Market Top Trends
Table Global Histoplasmosis Treatment Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Histoplasmosis Treatment Market Share by Manufacturers (2013-2018)
Figure Global Histoplasmosis Treatment Market Share by Manufacturers in 2018
Table Global Histoplasmosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Histoplasmosis Treatment Product/Solution/Service
Table Date of Enter into Histoplasmosis Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Histoplasmosis Treatment Market Size by Type (2013-2018) (Million US$)
Table Global Histoplasmosis Treatment Market Size Share by Type (2013-2018)
Figure Global Histoplasmosis Treatment Market Size Market Share by Type (2013-2018)
Table Global Histoplasmosis Treatment Market Size by Application (2013-2018) (Million US$)
Table Global Histoplasmosis Treatment Market Size Share by Application (2013-2018)
Figure Global Histoplasmosis Treatment Market Size Market Share by Application (2013-2018)
Figure Global Histoplasmosis Treatment Revenue Market Share by Application in 2017
Figure United States Histoplasmosis Treatment Market Size 2013-2018 (Million US$)
Table United States Key Players Histoplasmosis Treatment Revenue (2017-2018) (Million US$)
Table United States Key Players Histoplasmosis Treatment Market Share (2017-2018)
Table United States Histoplasmosis Treatment Market Size by Type (2013-2018) (Million US$)
Table United States Histoplasmosis Treatment Market Share by Type (2013-2018)
Table United States Histoplasmosis Treatment Market Size by Application (2013-2018) (Million US$)
Table United States Histoplasmosis Treatment Market Share by Application (2013-2018)
Figure Europe Histoplasmosis Treatment Market Size 2013-2018 (Million US$)
Table Europe Key Players Histoplasmosis Treatment Revenue (2017-2018) (Million US$)
Table Europe Key Players Histoplasmosis Treatment Market Share (2017-2018)
Table Europe Histoplasmosis Treatment Market Size by Type (2013-2018) (Million US$)
Table Europe Histoplasmosis Treatment Market Share by Type (2013-2018)
Table Europe Histoplasmosis Treatment Market Size by Application (2013-2018) (Million US$)
Table Europe Histoplasmosis Treatment Market Share by Application (2013-2018)
Figure China Histoplasmosis Treatment Market Size 2013-2018 (Million US$)
Table China Key Players Histoplasmosis Treatment Revenue (2017-2018) (Million US$)
Table China Key Players Histoplasmosis Treatment Market Share (2017-2018)
Table China Histoplasmosis Treatment Market Size by Type (2013-2018) (Million US$)
Table China Histoplasmosis Treatment Market Share by Type (2013-2018)
Table China Histoplasmosis Treatment Market Size by Application (2013-2018) (Million US$)
Table China Histoplasmosis Treatment Market Share by Application (2013-2018)
Figure Japan Histoplasmosis Treatment Market Size 2013-2018 (Million US$)
Table Japan Key Players Histoplasmosis Treatment Revenue (2017-2018) (Million US$)
Table Japan Key Players Histoplasmosis Treatment Market Share (2017-2018)
Table Japan Histoplasmosis Treatment Market Size by Type (2013-2018) (Million US$)
Table Japan Histoplasmosis Treatment Market Share by Type (2013-2018)
Table Japan Histoplasmosis Treatment Market Size by Application (2013-2018) (Million US$)
Table Japan Histoplasmosis Treatment Market Share by Application (2013-2018)
Figure Southeast Asia Histoplasmosis Treatment Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Histoplasmosis Treatment Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Histoplasmosis Treatment Market Share (2017-2018)
Table Southeast Asia Histoplasmosis Treatment Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Histoplasmosis Treatment Market Share by Type (2013-2018)
Table Southeast Asia Histoplasmosis Treatment Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Histoplasmosis Treatment Market Share by Application (2013-2018)
Figure India Histoplasmosis Treatment Market Size 2013-2018 (Million US$)
Table India Key Players Histoplasmosis Treatment Revenue (2017-2018) (Million US$)
Table India Key Players Histoplasmosis Treatment Market Share (2017-2018)
Table India Histoplasmosis Treatment Market Size by Type (2013-2018) (Million US$)
Table India Histoplasmosis Treatment Market Share by Type (2013-2018)
Table India Histoplasmosis Treatment Market Size by Application (2013-2018) (Million US$)
Table India Histoplasmosis Treatment Market Share by Application (2013-2018)
Figure Central & South America Histoplasmosis Treatment Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Histoplasmosis Treatment Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Histoplasmosis Treatment Market Share (2017-2018)
Table Central & South America Histoplasmosis Treatment Market Size by Type (2013-2018) (Million US$)
Table Central & South America Histoplasmosis Treatment Market Share by Type (2013-2018)
Table Central & South America Histoplasmosis Treatment Market Size by Application (2013-2018) (Million US$)
Table Central & South America Histoplasmosis Treatment Market Share by Application (2013-2018)
Table Bristol Myers Squibb Company Details
Table Bristol Myers Squibb Revenue in Histoplasmosis Treatment Business (2013-2018) (Million US$)
Figure Bristol Myers Squibb Revenue Growth Rate in Histoplasmosis Treatment Business (2013-2018)
Table Bristol Myers Squibb Recent Development
Table Sigma tau pharmaceuticals Inc. Company Details
Table Sigma tau pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2013-2018)(Million US$)
Figure Sigma tau pharmaceuticals Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2013-2018)
Table Sigma tau pharmaceuticals Inc. Recent Development
Table Three rivers pharmaceuticals Company Details
Table Three rivers pharmaceuticals Revenue in Histoplasmosis Treatment Business (2013-2018)(Million US$)
Figure Three rivers pharmaceuticals Revenue Growth Rate in Histoplasmosis Treatment Business (2013-2018)
Table Three rivers pharmaceuticals Recent Development
Table Astellas pharma US Inc. Company Details
Table Astellas pharma US Inc. Revenue in Histoplasmosis Treatment Business (2013-2018)(Million US$)
Figure Astellas pharma US Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2013-2018)
Table Astellas pharma US Inc. Recent Development
Table Abbott laboratories Company Details
Table Abbott laboratories Revenue in Histoplasmosis Treatment Business (2013-2018)(Million US$)
Figure Abbott laboratories Revenue Growth Rate in Histoplasmosis Treatment Business (2013-2018)
Table Abbott laboratories Recent Development
Table Abraxis pharmaceutical products Company Details
Table Abraxis pharmaceutical products Revenue in Histoplasmosis Treatment Business (2013-2018)(Million US$)
Figure Abraxis pharmaceutical products Revenue Growth Rate in Histoplasmosis Treatment Business (2013-2018)
Table Abraxis pharmaceutical products Recent Development
Table Teva parenteral medicines Inc. Company Details
Table Teva parenteral medicines Inc. Revenue in Histoplasmosis Treatment Business (2013-2018)(Million US$)
Figure Teva parenteral medicines Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2013-2018)
Table Teva parenteral medicines Inc. Recent Development
Table X gen pharmaceuticals Inc. Company Details
Table X gen pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2013-2018)(Million US$)
Figure X gen pharmaceuticals Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2013-2018)
Table X gen pharmaceuticals Inc. Recent Development
Table Global Histoplasmosis Treatment Market Size by Regions (Million US$) 2018-2025
Figure Global Histoplasmosis Treatment Market Size Share by Regions (2018-2025)
Figure Global Histoplasmosis Treatment Market Size Share by Regions in 2025
Figure United States Histoplasmosis Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Europe Histoplasmosis Treatment Market Size Forecast (2018-2025)(Million USD)
Figure China Histoplasmosis Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Japan Histoplasmosis Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Histoplasmosis Treatment Market Size Forecast (2018-2025)(Million USD)
Figure India Histoplasmosis Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Histoplasmosis Treatment Market Size Forecast (2018-2025)(Million USD)
Table Global Histoplasmosis Treatment Market Size by Product (2018-2025) (Million US$)
Figure Global Histoplasmosis Treatment Market Size by Product (2018-2025)
Figure Global Histoplasmosis Treatment Market Size by Product in 2025
Table Global Histoplasmosis Treatment Market Size by Application (2018-2025) (Million US$)
Figure Global Histoplasmosis Treatment Market Size by Application (2018-2025)
Figure Global Histoplasmosis Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
